Literature DB >> 24775607

Absence of association of FCGR2A gene polymorphism rs1801274 with Kawasaki disease in Greek patients.

Anthoula Chatzikyriakidou1, Louiza Aidinidou1, Andreas Giannopoulos2, Kyriaki Papadopoulou-Legbelou3, Kallirhoe Kalinderi1, Liana Fidani1.   

Abstract

Kawasaki disease is an acute, febrile syndrome in infancy, characterised by vasculitis of medium-sized arteries, and affects predominantly young children. Family-based studies on Kawasaki disease supports the contribution of genetic factors in disorder manifestation. In a recent genome-wide association study, the polymorphism rs1801274 of FCGR2A [Fc fragment of immunoglobulin G, low-affinity IIa, receptor] gene has been implicated in disease pathogenesis. The aim of the present study was to explore the association of this variant, for the first time, in a group of Kawasaki-diseased patients of Greek origin. A total of 47 Kawasaki-diseased children and 50 control subjects were enrolled in the study. Polymerase chain reaction-restriction fragment length polymorphism assay was performed in rs1801274 genotyping. No association was observed between this polymorphism genotypes' or alleles' distribution between Kawasaki-diseased patients and controls. Furthermore, no association was revealed between this polymorphism and cardiovascular complications in Kawasaki-diseased patients. In the literature, the reported data over this polymorphism association with Kawasaki disease in Caucasian patients are contradictory. In addition, the disease shows low prevalence in the Caucasian populations. Therefore, the independent genetic association studies on rs1801274 with Kawasaki disease in various Caucasian groups increase the amount of genetic data, which could be used in a future meta-analysis, increasing the statistical power of the resultant conclusions.

Entities:  

Keywords:  polymorphism

Mesh:

Substances:

Year:  2014        PMID: 24775607     DOI: 10.1017/S1047951114000626

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  4 in total

Review 1.  Use of corticosteroids during acute phase of Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  World J Clin Pediatr       Date:  2015-11-08

2.  Association of FCGR2A rs1801274 polymorphism with susceptibility to autoimmune diseases: A meta-analysis.

Authors:  Chang'e Zhang; Wenju Wang; Hong'e Zhang; Lulu Wei; Shuping Guo
Journal:  Oncotarget       Date:  2016-06-28

3.  Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease.

Authors:  Sietse Q Nagelkerke; Carline E Tacke; Willemijn B Breunis; Michael W T Tanck; Judy Geissler; Eileen Png; Long T Hoang; Joris van der Heijden; Ahmad N M Naim; Rae S M Yeung; Michael L Levin; Victoria J Wright; David P Burgner; Anne-Louise Ponsonby; Justine A Ellis; Rolando Cimaz; Chisato Shimizu; Jane C Burns; Karin Fijnvandraat; C Ellen van der Schoot; Timo K van den Berg; Martin de Boer; Sonia Davila; Martin L Hibberd; Taco W Kuijpers
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

Review 4.  Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.

Authors:  Bin Tang; Hang Hong Lo; Cheng Lei; Ka In U; Wen-Luan Wendy Hsiao; Xiaoling Guo; Jun Bai; Vincent Kam-Wai Wong; Betty Yuen-Kwan Law
Journal:  Phytomedicine       Date:  2020-03-18       Impact factor: 5.340

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.